




Searching News Database: Spectranetics
HSMN NewsFeed - 25 Jul 2016
QT Vascular Announces Federal Circuit Reversal of Adverse AngioScore / Spectranetics Judgment
QT Vascular Announces Federal Circuit Reversal of Adverse AngioScore / Spectranetics Judgment
HSMN NewsFeed - 30 Sep 2015
QT Vascular Announces Positive Outcome in Spectranetics/AngioScore Patent Trial
QT Vascular Announces Positive Outcome in Spectranetics/AngioScore Patent Trial
HSMN NewsFeed - 30 Sep 2015
Jury in Federal Court in California Finds Against AngioScore's Patent Infringement Claims
Jury in Federal Court in California Finds Against AngioScore's Patent Infringement Claims
HSMN NewsFeed - 27 Jan 2015
Spectranetics Completes Acquisition of Stellarex(TM) Drug Coated Balloon Assets From Covidien
Spectranetics Completes Acquisition of Stellarex(TM) Drug Coated Balloon Assets From Covidien
HSMN NewsFeed - 29 Jan 2013
Spectranetics Announces Expansion Into Japan Peripheral Intervention Market
Spectranetics Announces Expansion Into Japan Peripheral Intervention Market
HSMN NewsFeed - 12 Jul 2011
Spectranetics Appoints Scott Drake as President and Chief Executive Officer
Spectranetics Appoints Scott Drake as President and Chief Executive Officer
HSMN NewsFeed - 31 May 2011
Spectranetics Introduces First Advanced System for Simulation of Peripheral Vascular Arterial Occlusions
Spectranetics Introduces First Advanced System for Simulation of Peripheral Vascular Arterial Occlusions
HSMN NewsFeed - 7 Apr 2011
Spectranetics to Initiate Landmark Randomized Study of Laser Treatment for Peripheral Artery Disease
Spectranetics to Initiate Landmark Randomized Study of Laser Treatment for Peripheral Artery Disease
HSMN NewsFeed - 20 Jan 2011
Spectranetics Receives FDA Approval for Site Change Related to Manufacturing of CVX-300(R) Laser System
Spectranetics Receives FDA Approval for Site Change Related to Manufacturing of CVX-300(R) Laser System
HSMN NewsFeed - 7 Oct 2010
Spectranetics Announces Retirement of Chairman and CEO Emile J. Geisenheimer
Spectranetics Announces Retirement of Chairman and CEO Emile J. Geisenheimer
HSMN NewsFeed - 20 Jul 2010
Spectranetics Announces Reimbursement Approval for Laser-Assisted Lead Extraction in Japan
Spectranetics Announces Reimbursement Approval for Laser-Assisted Lead Extraction in Japan
HSMN NewsFeed - 23 Jun 2010
Kensey Nash Announces New Collagen Supply Agreement With St. Jude Medical
Kensey Nash Announces New Collagen Supply Agreement With St. Jude Medical
HSMN NewsFeed - 13 Jan 2010
Published Study Demonstrates Effectiveness of Spectranetics Turbo-Booster(R) for Peripheral Artery Disease
Published Study Demonstrates Effectiveness of Spectranetics Turbo-Booster(R) for Peripheral Artery Disease
HSMN NewsFeed - 3 Dec 2009
Spectranetics Announces FDA Clearance of VisiSheath Dilator Sheath, New Lead Management Device
Spectranetics Announces FDA Clearance of VisiSheath Dilator Sheath, New Lead Management Device
HSMN NewsFeed - 20 Aug 2009
Synthes and Kensey Nash Announce Strategic Agreement for Extracellular Matrix Products
Synthes and Kensey Nash Announce Strategic Agreement for Extracellular Matrix Products
HSMN NewsFeed - 25 Jun 2009
Spectranetics Names Jason Hein Senior VP, Sales, Marketing and Product Development
Spectranetics Names Jason Hein Senior VP, Sales, Marketing and Product Development
HSMN NewsFeed - 5 May 2009
Spectranetics Makes Pre-IDE Submission to FDA for the Treatment of In-Stent Restenosis in the Legs
Spectranetics Makes Pre-IDE Submission to FDA for the Treatment of In-Stent Restenosis in the Legs
HSMN NewsFeed - 4 May 2009
Data Shows Laser Assisted Lead Removal Effective: Spectranetics Releases Data from LExICon Study
Data Shows Laser Assisted Lead Removal Effective: Spectranetics Releases Data from LExICon Study
HSMN NewsFeed - 29 Jan 2009
Spectranetics Announces Executive Appointments to Further Enhance Compliance Programs
Spectranetics Announces Executive Appointments to Further Enhance Compliance Programs
HSMN NewsFeed - 21 Jan 2009
Spectranetics Reports on 12-Month CELLO Data at LINC Meeting in Leipzig, Germany
Spectranetics Reports on 12-Month CELLO Data at LINC Meeting in Leipzig, Germany
HSMN NewsFeed - 22 Oct 2008
Spectranetics Appoints Company Chairman, Emile J. Geisenheimer, as President and Chief Executive Officer
Spectranetics Appoints Company Chairman, Emile J. Geisenheimer, as President and Chief Executive Officer
HSMN NewsFeed - 13 Aug 2008
Spectranetics Takes Steps Targeted at Accelerating Vascular Intervention Growth
Spectranetics Takes Steps Targeted at Accelerating Vascular Intervention Growth
HSMN NewsFeed - 2 Jun 2008
Kensey Nash Announces the Closing on its Sale of the Endovascular Business to Spectranetics
Kensey Nash Announces the Closing on its Sale of the Endovascular Business to Spectranetics
HSMN NewsFeed - 2 Jun 2008
Spectranetics Announces Closing of Transaction to Acquire Endovascular Business of Kensey Nash
Spectranetics Announces Closing of Transaction to Acquire Endovascular Business of Kensey Nash
HSMN NewsFeed - 15 May 2008
Spectranetics Introduces New Device for Removal of Non-Functional and Infected Cardiac Leads
Spectranetics Introduces New Device for Removal of Non-Functional and Infected Cardiac Leads
HSMN NewsFeed - 13 May 2008
Kensey Nash Announces Sale of Endovascular Business and Strategic Partnership With Spectranetics
Kensey Nash Announces Sale of Endovascular Business and Strategic Partnership With Spectranetics
HSMN NewsFeed - 12 May 2008
Safe Options for Cardiac Lead Removal: Study Published in Heart Rhythm Journal
Safe Options for Cardiac Lead Removal: Study Published in Heart Rhythm Journal
HSMN NewsFeed - 14 Feb 2008
Spectranetics Appoints Thomas Rasmussen Vice President of Clinical Affairs
Spectranetics Appoints Thomas Rasmussen Vice President of Clinical Affairs
HSMN NewsFeed - 26 Sep 2007
Spectranetics Enrolls First Patient in PATENT Trial for the Treatment of Instent Restenosis
Spectranetics Enrolls First Patient in PATENT Trial for the Treatment of Instent Restenosis
HSMN NewsFeed - 12 Jul 2007
Spectranetics Receives FDA Clearance for Expanded Labeling for TURBO Elite
Spectranetics Receives FDA Clearance for Expanded Labeling for TURBO Elite
HSMN NewsFeed - 7 Jun 2007
Spectranetics Appoints Donald Fletcher Vice President of Quality Assurance and Regulatory Compliance
Spectranetics Appoints Donald Fletcher Vice President of Quality Assurance and Regulatory Compliance
HSMN NewsFeed - 9 May 2007
Spectranetics Appoints Larry Adighije Vice President, Business Development & Strategy
Spectranetics Appoints Larry Adighije Vice President, Business Development & Strategy
HSMN NewsFeed - 5 Apr 2007
Spectranetics Appoints Shar Matin Managing Director for European Operations
Spectranetics Appoints Shar Matin Managing Director for European Operations
HSMN NewsFeed - 12 Feb 2007
Spectranetics Hires Jeffrey Deming as New Vice President of Quality Assurance and Regulatory Compliance
Spectranetics Hires Jeffrey Deming as New Vice President of Quality Assurance and Regulatory Compliance
HSMN NewsFeed - 3 Jan 2007
Spectranetics Laser System Used in Neurovascular Surgery for First Time in U.S.
Spectranetics Laser System Used in Neurovascular Surgery for First Time in U.S.
HSMN NewsFeed - 18 Sep 2006
FoxHollow Technologies Increases Depth of Management Team With Two Senior Vice Presidents
FoxHollow Technologies Increases Depth of Management Team With Two Senior Vice Presidents
HSMN NewsFeed - 19 May 2006
Spectranetics CLiRpath(R) TURBO-Booster(TM) Featured in Live Case at EuroPCR
Spectranetics CLiRpath(R) TURBO-Booster(TM) Featured in Live Case at EuroPCR
Additional items found! 44

Members Archive contains
44 additional stories matching:
Spectranetics
(Password required)
Spectranetics
(Password required)